Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

ABX-IL-8 slated to enter clinical testing

Jan. 8, 1998

NDA filed for betamethasone mousse

Jan. 7, 1998

Biomatrix's Hyalform approved in additional markets; PMA resubmission planned in U.S.

Jan. 5, 1998

Structurally distinct vitamin D analogues from Leo

Jan. 5, 1998

FDA clears new oral treatment for hair loss in men

Dec. 29, 1997

Apligraf scheduled for FDA advisory panel review

Dec. 24, 1997

Life Medical Sciences terminates Piliel trials early; refocuses R&D efforts

Dec. 22, 1997

Antiacne activity of oral contraceptives

Dec. 19, 1997

AEterna's psoriasis agent moves to phase I/II in Canada

Dec. 18, 1997

First biologic approved for treatment of diabetic foot ulcers

Dec. 18, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...